Programme

09:30 – 11:00 MULTIDISCIPLINARY EDUCATIONAL SESSION
Managing woman-specific bleeding issues
11:00 – 11:30 Coffee Break
11:30 – 18:30 SATELLITE SYMPOSIA
11:30 – 12:45 Satellite symposia 1, 2, 3
12:45 – 13:45 Lunch Break
13:45 – 15:00 Satellite symposia 4, 5, 6
15:00 – 15:30 Coffee Break
15:30 – 16:45 Satellite symposia 7, 8, 9
16:45 – 17:15 Coffee Break
17:15 – 18:30 Satellite symposia 10, 11, 12
18:30 – 19:30 Welcome Reception and Poster Presentations
08:30 – 08:45 Welcome and Introduction K Fijn van Draat
08:45 – 09:15 SESSION 1: Next Nature
09:15 – 10:45 SESSION 2: Therapeutic Landscapes
09:15 – 09:45 Current therapeutic landscape for haemophilia B Nolan
09:45 – 10:15 Future therapeutic landscape for haemophilia TBC
10:15 – 10:45 Gene therapy TBC
10:45 – 11:15 Coffee Break/Poster Viewing
11:15 – 13:00 SESSION 3: Dubious Dilemmas in PUPs and Paediatric Patients
11:15 – 11:30 Case presentation: Clinical dilemmas in a newborn with haemophilia A N Gretenkort
11:30 – 12:00 PUP treatment and immune tolerance induction treatment M Mancuso
12:00 – 12:30 Gene therapy for children, ethical aspects TBC
12:30 – 13:00 Uncertainties in the era of new treatments: What patients think the safeguards should be C Smit
13:00 – 14:00 Lunch Break/Poster Viewing/EAHAD Annual General Meeting
14:00 – 15:30 SESSION 4: Diagnostic Discoveries
14:00 – 14:30 Future diagnostics of platelet disorders K Freson
14:30 – 15:00 Predicting joint damage L van Vulpen
15:00 – 15:30 Monitoring novel therapeutics P Lenting
15:30 – 16:00 Break
16:00 – 17:45 SESSION 5: Von Willebrand Factor/Disease: Throughout Real Life
16:00 – 16:15 Case presentation: Clinical dilemmas in a patient with VWD M Kruip
16:15 – 16:45 Circle of life of VWD patients F Leebeek
16:45 – 17:15 Low VWF M Lavin
17:15 – 17:45 PK of perioperative treatment in VWD patients G Castaman
20.00 – 00:00 Networking Evening
08:30 – 10:00 SESSION 6: SLAM
10 abstracts selected for oral presentation
10:00 – 10:30 Coffee Break/Poster Viewing
10:30 – 11:30 SESSION 7: Debate: Do we really need PK-based management?
YES, PK improves outcomes M Cnossen
NO, we don’t need PK to improve outcomes D Hart
11:30 – 12:00 EAHAD European Activities Update M Makris
12:00 – 12:30 Arosenius Lecture 2020
Haemophilia care in Europe B O’Mahony
12:30 – 13:15 Lunch Break
13:15 – 14:00 Poster and Research Awards
13:15 – 13:45 Reports from 2018 Research Grant winners:
  • Interactions between fibrinogen variants and blood cells: toward a predictive model in congenital fibrinogen disorders
  • R Marchi
  • High throughput generation and characterisation of monoclonal anti-FVIII IgG from patients with haemophilia A
  • S Lacroix-Desmazes
13:45 – 14:00 Award presentations
14:00 – 15:00 SESSION 8: Hot Topics
To be announced in January 2020
15:00 – 15:15 Closing Remarks K Fijn van Draat